Sponsored by Lonza 9 Sep 2025 Advanced expression vector design to overcome challenges in developing multichain biotherapeutics …gene of interest into the host cell line’s genome. For drug developers at an earlier stage, like candidate screening and selection, the GS Discovery® Transient Expression System enables them to… September 9, 2025 - 8 minutesmins - By Jennifer Tsang Share WhatsApp Twitter Linkedin Email
Biotech conferences and events 2022-2023 …Pace with Rapid Advancements in Multiple Myeloma Care, Washington, US 13-18 International Plant and Animal Genome Conference, San Diego, US 17-20 Advanced Therapies Week, Miami Beach, US 19 Show Me… December 13, 2023 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2019 European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm …the human genome. Named pHERV-W Env, this protein is linked to autoimmune attacks, so GeNeuro is testing it in another autoimmune condition, type 1 diabetes. Now that the trials have… September 17, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Sep 2024 Estonia: Seven biotech companies to reckon with …has developed genetic tests to estimate the risk of common cancers. Its polygenic risk score (PRS) sums up information over hundreds to thousands of genetic variants in the human genome…. September 17, 2024 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 25 Jul 2018 Could These Groundbreaking Therapies Make Conventional Antibiotics a Thing of the Past? …‘eligobiotics’, based on the revolutionary CRISPR genome editing technology. “Antibiotics are weapons of mass destruction: extremely powerful but imprecise. With eligobiotics, we can precisely intervene on the microbiome – targeting… July 25, 2018 - 5 minutesmins - By Farhan Mitha Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2025 Kriya Therapeutics has raised over $1.2 billion, but for what? …non-integrating since the gene does not insert itself into the person’s genome. The three candidates were KT-A112, KT-A522, and KT-A832 and their development was in collaboration with the Universitat Autònoma… September 10, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 3 Nov 2022 What’s on the horizon for gene editing-based therapies? …genome can be transmitted to new generations of cells, so gene editing therapies can be used in tissues with a higher turnover rate, such as the liver in young children…. November 3, 2022 - 8 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 6 Jun 2024 CRISPR: A promising path to treating blindness …out the disease genome for conditions causing blindness is critical to figuring out which pathologies can be targeted,” said Boparai. Moreover, the accuracy of the delivery as well as its… June 6, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Interview 22 Feb 2018 Could a New Approach Help Us to Overcome Resistance to HIV Treatment? …field. However, he highlighted the difficulty in getting rid of the virus from the body: “The problem is that HIV is inserted into the genome of infected cells like long-lived… February 22, 2018 - 4 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 12 Dec 2016 A New Antibiotic from Your Nose! Thanks to Functional Genomics Could your nose lead to major discoveries in antibiotic production? Genome mining of nose bacteria has revealed a new powerful antibiotic. Functional genomics offers a powerful tool for the isolation… December 12, 2016 - 2 minutesmins - By Joachim Eeckhout Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jan 2023 Blacksmith Medicines merging with Forge Therapeutics …containing a full characterization of the metalloenzyme genome including functions, metal cofactors, and associations to disease; and a first-of-its-kind metallo-CRISPR library of custom single guide RNAs. Blacksmith Medicines also has… January 3, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Oct 2023 Bridging Science and Art: Five bioartists you should know about …the pet, in 1997. Kac’s controversial piece, Alba, was a genetically-modified rabbit whose genome was engineered to have the green fluorescent protein (GFP) gene found in jellyfish, that fluoresces green… October 10, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email